YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Sanofi to buy Kymab for $1.1B

Posted online

French pharmaceutical company Sanofi SA signed on to purchase United Kingdom-based Kymab for $1.1 billion.

The acquisition of the biopharmaceutical company also includes payments of up to $350 million upon the achievement of certain milestones.

Kymab focuses on developing fully human monoclonal antibodies.

Read more from MarketWatch.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open For Business: Thunder Thrift

A Sept. 25 ribbon-cutting ceremony marked the public debut of Thunder Thrift, a volunteer-run shop created by Springfield Lutheran High School.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences